+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Adhesion Barrier Market by End User, Product Type, Application - Global Forecast to 2030

  • PDF Icon

    Report

  • 197 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5234117
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Adhesion Barrier Market grew from USD 866.69 million in 2024 to USD 933.62 million in 2025. It is expected to continue growing at a CAGR of 7.36%, reaching USD 1.32 billion by 2030.

Addressing Surgical Adhesions with Advanced Barrier Solutions

Surgical adhesions represent a persistent challenge, giving rise to complications such as chronic pain, infertility, and repeated operations. As minimally invasive procedures proliferate alongside heightened patient expectations for rapid recovery, the demand for effective adhesion barrier solutions has never been greater. Innovative materials and delivery methods are redefining how surgeons mitigate postoperative scar tissue, shifting the market toward higher-performance products that seamlessly integrate with advanced surgical workflows.

Clinicians and healthcare administrators are seeking barrier systems that combine ease of application with reliable efficacy across diverse procedures. Concurrently, regulatory agencies are streamlining approvals for next-generation materials, while reimbursement frameworks evolve to recognize the long-term cost savings of adhesion prevention. These converging forces create a dynamic ecosystem in which manufacturers and providers must collaborate to translate technological breakthroughs into improved patient outcomes and operational efficiencies.

Emerging Innovations Reshaping the Adhesion Barrier Landscape

The adhesion barrier landscape is undergoing transformative shifts as novel chemistries and manufacturing techniques emerge. Bioresorbable polymers engineered at the molecular level now offer tunable degradation profiles, enabling barriers to persist precisely through the critical phases of wound healing. Concurrently, the integration of anti-inflammatory or anti-fibrotic agents within barrier matrices is expanding therapeutic potential, positioning these products not just as physical separators but as active modulators of the healing cascade.

On the procedural front, the rapid adoption of robotic and laparoscopic platforms is driving demand for barrier systems optimized for minimally invasive access. Companies are responding with sprayable gels and ultra-thin films that conform to intricate anatomical sites under endoscopic guidance. Meanwhile, manufacturing innovations-such as solvent-free extrusion and precision coating-are enhancing product consistency and reducing environmental footprint. Together, these advances are establishing a new benchmark in adhesion prevention and creating fertile ground for strategic partnerships.

Assessing the Effect of 2025 US Tariffs on Adhesion Barrier Economics

New tariff measures effective in 2025 are poised to influence the economics of adhesion barrier production and distribution in the United States. Import duties on key raw materials, including specialized polymers and bioactive compounds, are increasing input costs for manufacturers reliant on overseas supply chains. As a result, producers are re-evaluating sourcing strategies, with some shifting toward domestic suppliers and alternative chemistries to mitigate margin pressure.

These changes are prompting operational adjustments across the value chain. Contract manufacturers with US-based facilities are experiencing heightened interest as companies seek to preserve cost competitiveness. In parallel, distributors are recalibrating pricing models and renegotiating service agreements to maintain alignment with end users’ budget cycles. Although tariffs introduce near-term volatility, they also catalyze investment in local capacity and supply chain resilience-factors that will underpin long-term market stability and innovation.

Unveiling Segmentation Patterns Driving Barrier Technology Adoption

Analysis of user categories reveals distinct procurement behaviors that influence product development and commercial strategies. Ambulatory surgical centers operate either as freestanding enterprises or under hospital affiliation, with the former favoring streamlined protocols and rapid turnover, while the latter leverage integrated supply contracts and bulk purchasing power. Hospital environments encompass private institutions that prioritize premium, differentiated solutions and public hospitals that emphasize cost containment and broad formulary acceptance. Specialized clinics, including fertility centers and dedicated outpatient facilities, demand tailored barrier profiles that align with procedure-specific risk profiles and high patient throughput.

Product segmentation highlights the continued dominance of film barriers, valued for handling ease and conformability, alongside robust growth in gel formulations designed for cavitary and laparoscopic interventions. Powder variants, meanwhile, address niche requirements in irregular spaces and complex geometries. Application segmentation underscores the breadth of clinical adoption: cardiovascular surgery covers coronary artery bypass grafting and valve replacement, general surgery spans laparoscopic and open approaches, gynecology includes hysterectomy and myomectomy, and orthopedic procedures range from joint replacement to spinal fusion. These intersecting layers of end-user, product type, and application inform differentiated go-to-market strategies and prioritize areas for future innovation.

Regional Dynamics Shaping Global Adhesion Barrier Deployment

Regional dynamics underscore how local healthcare infrastructures, regulatory frameworks, and patient demographics shape adhesion barrier utilization. In the Americas, advanced reimbursement models and high procedure volumes foster rapid uptake of premium barrier systems, while supply chain investments support consistent market access. Public-private partnerships and value-based care initiatives further incentivize providers to adopt technologies that reduce readmissions and long-term costs.

Within Europe, the Middle East and Africa, heterogeneous regulatory regimes and variable healthcare funding create complex entry requirements. Western European markets lead in adopting cutting-edge materials, whereas emerging EMEA economies show growing interest in cost-effective alternatives that can scale across diverse care settings. Collaborative initiatives between governments and industry are streamlining approvals, accelerating regional harmonization.

In Asia-Pacific, expanding surgical capacity and an aging population drive sustained demand. Robust infrastructure development in key markets is complemented by proactive government programs aimed at improving surgical outcomes. Local manufacturing capabilities are evolving to meet both domestic needs and export opportunities, positioning the region as a future nexus of production and innovation.

Competitive Landscape and Leading Players in Adhesion Barriers

The competitive landscape features a blend of established medical device conglomerates and agile specialty companies. Leading developers leverage deep R&D resources to advance next-generation barrier formulations, while smaller innovators focus on niche applications and rapid commercialization. Strategic alliances, joint ventures, and licensing agreements are commonplace as firms seek to complement internal capabilities and broaden geographic reach.

Some players differentiate through integrated solution platforms, combining barrier products with advanced delivery systems or digital surgical guidance tools. Others pursue vertical integration, securing raw material supply or expanding manufacturing capacity to optimize cost structures. M&A activity remains robust, driven by the imperative to acquire novel chemistries and accelerate market penetration. Across the spectrum, organizational agility and commitment to evidence generation-through clinical studies and real-world data collection-serve as critical differentiators in navigating complex procurement processes and earning clinician trust.

Strategic Imperatives for Industry Leaders to Seize Growth

Industry leaders should prioritize multi-dimensional innovation that integrates material science with digital enablement, ensuring barrier solutions meet evolving surgical demands. Cementing partnerships with leading healthcare institutions to generate robust clinical evidence will accelerate adoption and support favorable reimbursement decisions. Simultaneously, diversifying supply chains through strategic relationships with domestic suppliers and alternative raw material developers will build resilience against geopolitical shifts and tariff pressures.

Investing in modular, minimally invasive delivery technologies will unlock new procedural applications, while OEM collaborations can streamline product development pathways. Market participants should also engage proactively with payers and health technology assessment bodies to underscore the long-term value of adhesion prevention. Finally, expanding presence in high-growth outpatient and specialized clinic settings will enhance market coverage and drive incremental volume growth.

Rigorous Methodology Underpinning Adhesion Barrier Insights

This analysis is grounded in a rigorous methodology combining primary interviews with key opinion leaders, including surgeons, procurement managers, and regulatory experts, alongside comprehensive secondary research from peer-reviewed journals, patent filings, and industry publications. Data triangulation ensures validation across diverse information sources, while structured market maps and value-chain analyses clarify competitive positioning and technology trends.

Additional layers of scrutiny involve quantitative assessments of surgical procedure distributions, reimbursement frameworks, and geographic adoption patterns. Expert workshops and advisory panels further refine insights, testing hypotheses and stress-testing scenario outcomes. This multifaceted approach delivers a nuanced understanding of both current market dynamics and emerging opportunities.

Synthesizing Insights: Conclusions on Adhesion Barrier Trends

The convergence of material innovations, evolving surgical practices, and regulatory dynamics is reshaping the adhesion barrier market. Advanced bioresorbable materials and drug-eluting systems are elevating efficacy expectations, while manufacturing and delivery enhancements are broadening clinical applicability. Tariff-driven supply chain realignments underscore the importance of resilient procurement frameworks, and regional diversifications highlight the need for tailored market approaches.

Leading organizations that successfully integrate clinical evidence generation, strategic partnerships, and supply chain agility will establish sustainable competitive advantage. As healthcare systems continue to prioritize value and patient outcomes, adhesion barrier solutions positioned at the nexus of innovation and practical utility will command increasing importance across surgical disciplines.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • End User
    • Ambulatory Surgical Centers
      • Freestanding
      • Hospital Affiliated
    • Hospitals
      • Private
      • Public
    • Specialized Clinics
      • Fertility Clinics
      • Outpatient Centers
  • Product Type
    • Film
    • Gel
    • Powder
  • Application
    • Cardiovascular Surgery
      • Coronary Artery Bypass
      • Valve Replacement
    • General Surgery
      • Laparoscopic Surgery
      • Open Surgery
    • Gynecology
      • Hysterectomy
      • Myomectomy
    • Orthopedic Surgery
      • Joint Replacement
      • Spinal Surgery
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Johnson & Johnson
  • Baxter International Inc.
  • Sanofi S.A.
  • Medtronic plc
  • Integra LifeSciences Holdings Corporation
  • B. Braun Melsungen AG
  • Covalon Technologies Ltd.
  • Kaken Pharmaceutical Co., Ltd.
  • FzioMed Inc.
  • Confluent Surgical, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Adhesion Barrier Market, by End User
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.2.1. Freestanding
8.2.2. Hospital Affiliated
8.3. Hospitals
8.3.1. Private
8.3.2. Public
8.4. Specialized Clinics
8.4.1. Fertility Clinics
8.4.2. Outpatient Centers
9. Adhesion Barrier Market, by Product Type
9.1. Introduction
9.2. Film
9.3. Gel
9.4. Powder
10. Adhesion Barrier Market, by Application
10.1. Introduction
10.2. Cardiovascular Surgery
10.2.1. Coronary Artery Bypass
10.2.2. Valve Replacement
10.3. General Surgery
10.3.1. Laparoscopic Surgery
10.3.2. Open Surgery
10.4. Gynecology
10.4.1. Hysterectomy
10.4.2. Myomectomy
10.5. Orthopedic Surgery
10.5.1. Joint Replacement
10.5.2. Spinal Surgery
11. Americas Adhesion Barrier Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa Adhesion Barrier Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific Adhesion Barrier Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Johnson & Johnson
14.3.2. Baxter International Inc.
14.3.3. Sanofi S.A.
14.3.4. Medtronic plc
14.3.5. Integra LifeSciences Holdings Corporation
14.3.6. B. Braun Melsungen AG
14.3.7. Covalon Technologies Ltd.
14.3.8. Kaken Pharmaceutical Co., Ltd.
14.3.9. FzioMed Inc.
14.3.10. Confluent Surgical, Inc.
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. ADHESION BARRIER MARKET MULTI-CURRENCY
FIGURE 2. ADHESION BARRIER MARKET MULTI-LANGUAGE
FIGURE 3. ADHESION BARRIER MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ADHESION BARRIER MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ADHESION BARRIER MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ADHESION BARRIER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ADHESION BARRIER MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ADHESION BARRIER MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ADHESION BARRIER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS ADHESION BARRIER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ADHESION BARRIER MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES ADHESION BARRIER MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ADHESION BARRIER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ADHESION BARRIER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC ADHESION BARRIER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC ADHESION BARRIER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ADHESION BARRIER MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. ADHESION BARRIER MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ADHESION BARRIER MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ADHESION BARRIER MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ADHESION BARRIER MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ADHESION BARRIER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ADHESION BARRIER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ADHESION BARRIER MARKET SIZE, BY FREESTANDING, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ADHESION BARRIER MARKET SIZE, BY HOSPITAL AFFILIATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ADHESION BARRIER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ADHESION BARRIER MARKET SIZE, BY PRIVATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ADHESION BARRIER MARKET SIZE, BY PUBLIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ADHESION BARRIER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ADHESION BARRIER MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ADHESION BARRIER MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ADHESION BARRIER MARKET SIZE, BY OUTPATIENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ADHESION BARRIER MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ADHESION BARRIER MARKET SIZE, BY FILM, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ADHESION BARRIER MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ADHESION BARRIER MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ADHESION BARRIER MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ADHESION BARRIER MARKET SIZE, BY CORONARY ARTERY BYPASS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ADHESION BARRIER MARKET SIZE, BY VALVE REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ADHESION BARRIER MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ADHESION BARRIER MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ADHESION BARRIER MARKET SIZE, BY LAPAROSCOPIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ADHESION BARRIER MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ADHESION BARRIER MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ADHESION BARRIER MARKET SIZE, BY GYNECOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ADHESION BARRIER MARKET SIZE, BY HYSTERECTOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ADHESION BARRIER MARKET SIZE, BY MYOMECTOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ADHESION BARRIER MARKET SIZE, BY GYNECOLOGY, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ADHESION BARRIER MARKET SIZE, BY JOINT REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ADHESION BARRIER MARKET SIZE, BY SPINAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS ADHESION BARRIER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS ADHESION BARRIER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS ADHESION BARRIER MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS ADHESION BARRIER MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS ADHESION BARRIER MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS ADHESION BARRIER MARKET SIZE, BY GYNECOLOGY, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS ADHESION BARRIER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES ADHESION BARRIER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES ADHESION BARRIER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES ADHESION BARRIER MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES ADHESION BARRIER MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES ADHESION BARRIER MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES ADHESION BARRIER MARKET SIZE, BY GYNECOLOGY, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES ADHESION BARRIER MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 62. CANADA ADHESION BARRIER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. CANADA ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 64. CANADA ADHESION BARRIER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 65. CANADA ADHESION BARRIER MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 66. CANADA ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 67. CANADA ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. CANADA ADHESION BARRIER MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 69. CANADA ADHESION BARRIER MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 70. CANADA ADHESION BARRIER MARKET SIZE, BY GYNECOLOGY, 2018-2030 (USD MILLION)
TABLE 71. CANADA ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 72. MEXICO ADHESION BARRIER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. MEXICO ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 74. MEXICO ADHESION BARRIER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 75. MEXICO ADHESION BARRIER MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 76. MEXICO ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 77. MEXICO ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. MEXICO ADHESION BARRIER MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 79. MEXICO ADHESION BARRIER MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 80. MEXICO ADHESION BARRIER MARKET SIZE, BY GYNECOLOGY, 2018-2030 (USD MILLION)
TABLE 81. MEXICO ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL ADHESION BARRIER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL ADHESION BARRIER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL ADHESION BARRIER MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL ADHESION BARRIER MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL ADHESION BARRIER MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL ADHESION BARRIER MARKET SIZE, BY GYNECOLOGY, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA ADHESION BARRIER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA ADHESION BARRIER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA ADHESION BARRIER MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA ADHESION BARRIER MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA ADHESION BARRIER MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA ADHESION BARRIER MARKET SIZE, BY GYNECOLOGY, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA ADHESION BARRIER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA ADHESION BARRIER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA ADHESION BARRIER MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA ADHESION BARRIER MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA ADHESION BARRIER MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA ADHESION BARRIER MARKET SIZE, BY GYNECOLOGY, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA ADHESION BARRIER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM ADHESION BARRIER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. UNITED KINGDOM ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM ADHESION BARRIER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 116. UNITED KINGDOM ADHESION BARRIER MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM ADHESION BARRIER MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM ADHESION BARRIER MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM ADHESION BARRIER MARKET SIZE, BY GYNECOLOGY, 2018-2030 (USD MILLION)
TABLE 122. UNITED KINGDOM ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 123. GERMANY ADHESION BARRIER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. GERMANY ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 125. GERMANY ADHESION BARRIER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 126. GERMANY ADHESION BARRIER MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 127. GERMANY ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 128. GERMANY ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. GERMANY ADHESION BARRIER MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 130. GERMANY ADHESION BARRIER MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 131. GERMANY ADHESION BARRIER MARKET SIZE, BY GYNECOLOGY, 2018-2030 (USD MILLION)
TABLE 132. GERMANY ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 133. FRANCE ADHESION BARRIER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. FRANCE ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 135. FRANCE ADHESION BARRIER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 136. FRANCE ADHESION BARRIER MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 137. FRANCE ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 138. FRANCE ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. FRANCE ADHESION BARRIER MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 140. FRANCE ADHESION BARRIER MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 141. FRANCE ADHESION BARRIER MARKET SIZE, BY GYNECOLOGY, 2018-2030 (USD MILLION)
TABLE 142. FRANCE ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 143. RUSSIA ADHESION BARRIER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. RUSSIA ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 145. RUSSIA ADHESION BARRIER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 146. RUSSIA ADHESION BARRIER MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 147. RUSSIA ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 148. RUSSIA ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. RUSSIA ADHESION BARRIER MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA ADHESION BARRIER MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA ADHESION BARRIER MARKET SIZE, BY GYNECOLOGY, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 153. ITALY ADHESION BARRIER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. ITALY ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 155. ITALY ADHESION BARRIER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 156. ITALY ADHESION BARRIER MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 157. ITALY ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 158. ITALY ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. ITALY ADHESION BARRIER MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 160. ITALY ADHESION BARRIER MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 161. ITALY ADHESION BARRIER MARKET SIZE, BY GYNECOLOGY, 2018-2030 (USD MILLION)
TABLE 162. ITALY ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 163. SPAIN ADHESION BARRIER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 164. SPAIN ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 165. SPAIN ADHESION BARRIER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 166. SPAIN ADHESION BARRIER MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 167. SPAIN ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 168. SPAIN ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. SPAIN ADHESION BARRIER MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 170. SPAIN ADHESION BARRIER MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 171. SPAIN ADHESION BARRIER MARKET SIZE, BY GYNECOLOGY, 2018-2030 (USD MILLION)
TABLE 172. SPAIN ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 173. UNITED ARAB EMIRATES ADHESION BARRIER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. UNITED ARAB EMIRATES ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 175. UNITED ARAB EMIRATES ADHESION BARRIER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 176. UNITED ARAB EMIRATES ADHESION BARRIER MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 177. UNITED ARAB EMIRATES ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES ADHESION BARRIER MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES ADHESION BARRIER MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES ADHESION BARRIER MARKET SIZE, BY GYNECOLOGY, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 183. SAUDI ARABIA ADHESION BARRIER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. SAUDI ARABIA ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 185. SAUDI ARABIA ADHESION BARRIER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 186. SAUDI ARABIA ADHESION BARRIER MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 187. SAUDI ARABIA ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 188. SAUDI ARABIA ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. SAUDI ARABIA ADHESION BARRIER MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 190. SAUDI ARABIA ADHESION BARRIER MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA ADHESION BARRIER MARKET SIZE, BY GYNECOLOGY, 2018-2030 (USD MILLION)
TABLE 192. SAUDI ARABIA ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 193. SOUTH AFRICA ADHESION BARRIER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. SOUTH AFRICA ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 195. SOUTH AFRICA ADHESION BARRIER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 196. SOUTH AFRICA ADHESION BARRIER MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 197. SOUTH AFRICA ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA ADHESION BARRIER MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA ADHESION BARRIER MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA ADHESION BARRIER MARKET SIZE, BY GYNECOLOGY, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 203. DENMARK ADHESION BARRIER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. DENMARK ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 205. DENMARK ADHESION BARRIER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 206. DENMARK ADHESION BARRIER MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 207. DENMARK ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 208. DENMARK ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. DENMARK ADHESION BARRIER MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 210. DENMARK ADHESION BARRIER MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 211. DENMARK ADHESION BARRIER MARKET SIZE, BY GYNECOLOGY, 2018-2030 (USD MILLION)
TABLE 212. DENMARK ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 213. NETHERLANDS ADHESION BARRIER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. NETHERLANDS ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 215. NETHERLANDS ADHESION BARRIER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 216. NETHERLANDS ADHESION BARRIER MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 217. NETHERLANDS ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 218. NETHERLANDS ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. NETHERLANDS ADHESION BARRIER MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 220. NETHERLANDS ADHESION BARRIER MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 221. NETHERLANDS ADHESION BARRIER MARKET SIZE, BY GYNECOLOGY, 2018-2030 (USD MILLION)
TABLE 222. NETHERLANDS ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 223. QATAR ADHESION BARRIER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 224. QATAR ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 225. QATAR ADHESION BARRIER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 226. QATAR ADHESION BARRIER MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 227. QATAR ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 228. QATAR ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. QATAR ADHESION BARRIER MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 230. QATAR ADHESION BARRIER MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 231. QATAR ADHESION BARRIER MARKET SIZE, BY GYNECOLOGY, 2018-2030 (USD MILLION)
TABLE 232. QATAR ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 233. FINLAND ADHESION BARRIER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 234. FINLAND ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 235. FINLAND ADHESION BARRIER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 236. FINLAND ADHESION BARRIER MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 237. FINLAND ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 238. FINLAND ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 239. FINLAND ADHESION BARRIER MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 240. FINLAND ADHESION BARRIER MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 241. FINLAND ADHESION BARRIER MARKET SIZE, BY GYNECOLOGY, 2018-2030 (USD MILLION)
TABLE 242. FINLAND ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 243. SWEDEN ADHESION BARRIER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 244. SWEDEN ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 245. SWEDEN ADHESION BARRIER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 246. SWEDEN ADHESION BARRIER MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 247. SWEDEN ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 248. SWEDEN ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN ADHESION BARRIER MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN ADHESION BARRIER MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN ADHESION BARRIER MARKET SIZE, BY GYNECOLOGY, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 253. NIGERIA ADHESION BARRIER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 254. NIGERIA ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 255. NIGERIA ADHESION BARRIER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 256. NIGERIA ADHESION BARRIER MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 257. NIGERIA ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 258. NIGERIA ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 259. NIGERIA ADHESION BARRIER MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 260. NIGERIA ADHESION BARRIER MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 261. NIGERIA ADHESION BARRIER MARKET SIZE, BY GYNECOLOGY, 2018-2030 (USD MILLION)
TABLE 262. NIGERIA ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 263. EGYPT ADHESION BARRIER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. EGYPT ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 265. EGYPT ADHESION BARRIER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 266. EGYPT ADHESION BARRIER MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 267. EGYPT ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 268. EGYPT ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. EGYPT ADHESION BARRIER MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 270. EGYPT ADHESION BARRIER MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 271. EGYPT ADHESION BARRIER MARKET SIZE, BY GYNECOLOGY, 2018-2030 (USD MILLION)
TABLE 272. EGYPT ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 273. TURKEY ADHESION BARRIER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. TURKEY ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 275. TURKEY ADHESION BARRIER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 276. TURKEY ADHESION BARRIER MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 277. TURKEY ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 278. TURKEY ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 279. TURKEY ADHESION BARRIER MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 280. TURKEY ADHESION BARRIER MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 281. TURKEY ADHESION BARRIER MARKET SIZE, BY GYNECOLOGY, 2018-2030 (USD MILLION)
TABLE 282. TURKEY ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 283. ISRAEL ADHESION BARRIER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. ISRAEL ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 285. ISRAEL ADHESION BARRIER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 286. ISRAEL ADHESION BARRIER MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 287. ISRAEL ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 288. ISRAEL ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 289. ISRAEL ADHESION BARRIER MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 290. ISRAEL ADHESION BARRIER MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 291. ISRAEL ADHESION BARRIER MARKET SIZE, BY GYNECOLOGY, 2018-2030 (USD MILLION)
TABLE 292. ISRAEL ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 293. NORWAY ADHESION BARRIER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 294. NORWAY ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 295. NORWAY ADHESION BARRIER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 296. NORWAY ADHESION BARRIER MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 297. NORWAY ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 298. NORWAY ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 299. NORWAY ADHESION BARRIER MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 300. NORWAY ADHESION BARRIER MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 301. NORWAY ADHESION BARRIER MARKET SIZE, BY GYNECOLOGY, 2018-2030 (USD MILLION)
TABLE 302. NORWAY ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 303. POLAND ADHESION BARRIER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 304. POLAND ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 305. POLAND ADHESION BARRIER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 306. POLAND ADHESION BARRIER MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 307. POLAND ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 308. POLAND ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 309. POLAND ADHESION BARRIER MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 310. POLAND ADHESION BARRIER MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 311. POLAND ADHESION BARRIER MARKET SIZE, BY GYNECOLOGY, 2018-2030 (USD MILLION)
TABLE 312. POLAND ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 313. SWITZERLAND ADHESION BARRIER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 314. SWITZERLAND ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 315. SWITZERLAND ADHESION BARRIER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 316. SWITZERLAND ADHESION BARRIER MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 317. SWITZERLAND ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 318. SWITZERLAND ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 319. SWITZERLAND ADHESION BARRIER MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 320. SWITZERLAND ADHESION BARRIER MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 321. SWITZERLAND ADHESION BARRIER MARKET SIZE, BY GYNECOLOGY, 2018-2030 (USD MILLION)
TABLE 322. SWITZERLAND ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 323. ASIA-PACIFIC ADHESION BARRIER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 324. ASIA-PACIFIC ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 325. ASIA-PACIFIC ADHESION BARRIER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 326. ASIA-PACIFIC ADHESION BARRIER MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 327. ASIA-PACIFIC ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 328. ASIA-PACIFIC ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 329. ASIA-PACIFIC ADHESION BARRIER MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 330. ASIA-PACIFIC ADHESION BARRIER MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 331. ASIA-PACIFIC ADHESION BARRIER MARKET SIZE, BY GYNECOLOGY, 2018-2030 (USD MILLION)
TABLE 332. ASIA-PACIFIC ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 333. ASIA-PACIFIC ADHESION BARRIER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 334. CHINA ADHESION BARRIER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 335. CHINA ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 336. CHINA ADHESION BARRIER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 337. CHINA ADHESION BARRIER MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 338. CHINA ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 339. CHINA ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 340. CHINA ADHESION BARRIER MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 341. CHINA ADHESION BARRIER MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 342. CHINA ADHESION BARRIER MARKET SIZE, BY GYNECOLOGY, 2018-2030 (USD MILLION)
TABLE 343. CHINA ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 344. INDIA ADHESION BARRIER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 345. INDIA ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 346. INDIA ADHESION BARRIER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 347. INDIA ADHESION BARRIER MARKET SIZE,

Companies Mentioned

The companies profiled in this Adhesion Barrier market report include:
  • Johnson & Johnson
  • Baxter International Inc.
  • Sanofi S.A.
  • Medtronic plc
  • Integra LifeSciences Holdings Corporation
  • B. Braun Melsungen AG
  • Covalon Technologies Ltd.
  • Kaken Pharmaceutical Co., Ltd.
  • FzioMed Inc.
  • Confluent Surgical, Inc.

Methodology

Loading
LOADING...

Table Information